TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28332904

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation
Number of subjects: 86

Group type: COMPARATOR
Intervention: Surgical turbinoplasty
Number of subjects: 86
Study: 24924232

Group type: EXPERIMENTAL
Intervention: Tr14
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 23579764

Group type: EXPERIMENTAL
Intervention: exEMS
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: limEMS
Number of subjects: 60

Group type: COMPARATOR
Intervention: CG
Number of subjects: 60
Study: 21433074

Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: d‐chlorpheniramine 2 mg
Number of subjects: 11
Study: 19767812

Group type: EXPERIMENTAL
Intervention: Caffeine ingestion (5 mg/kg fat-free mass; approximately 208-270 mg)
Number of subjects: 20
Study: 17530941

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (3.5 mg.kg(‐1) once weekly for 6 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (saline injections once weekly for 6 weeks)
Number of subjects: 16
Study: 16123572

Group type: EXPERIMENTAL
Intervention: Totally extraperitoneal preperitoneal hernia repair (TEP)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Lichtenstein hernia repair (LHR)
Number of subjects: 26
Study: 11949239

Group type: EXPERIMENTAL
Intervention: Compression bandaging
Number of subjects: 84

Group type: COMPARATOR
Intervention: Cryo-pad technology
Number of subjects: 84
Study: 10673907

Group type: COMPARATOR
Intervention: 0 micrograms Se/d (as selenomethionine)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 10 micrograms Se/d (as selenomethionine)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 20 micrograms Se/d (as selenomethionine)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 30 micrograms Se/d (as selenomethionine)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 40 micrograms Se/d (as selenomethionine)
Number of subjects: 44
Study: 7756106

Group type: EXPERIMENTAL
Intervention: N-acetyltransferase NAT1 activity in cystic fibrosis patients (n = 4)
Number of subjects: 39

Group type: COMPARATOR
Intervention: N-acetyltransferase NAT1 activity in control subjects (n = 9)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Km and Vmax values of NAT1 in MNL from CF patients
Number of subjects: 39

Group type: COMPARATOR
Intervention: Km and Vmax values of NAT1 in MNL from control subjects
Number of subjects: 39
Study: 2258378

Group type: EXPERIMENTAL
Intervention: Sertraline (145 mg daily)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Amitriptyline (104 mg daily)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 6795614

Group type: EXPERIMENTAL
Intervention: 750 mg cefuroxime i.m. with premedication and then 8 hourly for 3 days (group A)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 1.5 g cefuroxime i.v. at the time of induction of anaesthesia (group B)
Number of subjects: 114

Group type: COMPARATOR
Intervention: No treatment (group C)
Number of subjects: 114
Study: 31740387

Group type: EXPERIMENTAL
Intervention: Exercise training (ET)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Omega-3 PUFA supplementation
Number of subjects: 55
Study: 31484559

Group type: EXPERIMENTAL
Intervention: Basic acupuncture (BA)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Acupoint specificity (AS)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Needle duration (ND)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 32
Study: 27986838

Group type: EXPERIMENTAL
Intervention: Cornstarch-based gel
Number of subjects: 34

Group type: COMPARATOR
Intervention: Commercial gel
Number of subjects: 34
Study: 25378208

Group type: EXPERIMENTAL
Intervention: Accelerated weightbearing (AWB) group allowed full weightbearing after 6 weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Delayed weightbearing (DWB) group allowed full weightbearing after 10 weeks
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: MRI-based variables (bone edema, effusion) and KOOS
Number of subjects: 31
Study: 23910063

Group type: EXPERIMENTAL
Intervention: Risperidone 2 mg orally before ERCP
Number of subjects: 483

Group type: COMPARATOR
Intervention: Placebo orally before ERCP
Number of subjects: 483
Study: 21763472

Group type: EXPERIMENTAL
Intervention: Prolonged expiration breathing (2-s inspired time and 4-s expired time)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Spontaneous breathing without any constraints
Number of subjects: 11
Study: 19499864

Group type: EXPERIMENTAL
Intervention: GEB-guided PLMA insertion
Number of subjects: 96

Group type: COMPARATOR
Intervention: Introducer tool technique
Number of subjects: 96

Group type: COMPARATOR
Intervention: Digital technique
Number of subjects: 96
Study: 16428482

Group type: EXPERIMENTAL
Intervention: High levels of p95HER-2 in primary tumor tissue
Number of subjects: 483

Group type: EXPERIMENTAL
Intervention: Low levels of p95HER-2 in primary tumor tissue
Number of subjects: 483

Group type: COMPARATOR
Intervention: High levels of p185HER-2
Number of subjects: 483

Group type: EXPERIMENTAL
Intervention: High p95HER-2
Number of subjects: 483
Study: 15603203

Group type: EXPERIMENTAL
Intervention: 75 mg of pure histamine (equaling 124 mg histamine dihydrochloride, dissolved in peppermint tea)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (peppermint tea)
Number of subjects: 10
Study: 11730650

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005%
Number of subjects: 39
Study: 9078931

Group type: EXPERIMENTAL
Intervention: Ultrasound assessment of vocal cord function
Number of subjects: 27
Study: 8102552

Group type: EXPERIMENTAL
Intervention: Selegiline 10 mg/day
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 2884860

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 54

Group type: COMPARATOR
Intervention: Terazosin
Number of subjects: 54
Study: 31147478

Group type: EXPERIMENTAL
Intervention: $30 per call for taking up to five Wisconsin Tobacco Quit Line (WTQL) calls
Number of subjects: 1900

Group type: EXPERIMENTAL
Intervention: $20 per call for the first four WTQL calls and $70 for the fifth WTQL call
Number of subjects: 1900

Group type: EXPERIMENTAL
Intervention: Variable payments with $20 for the first four calls and $70 for the fifth call
Number of subjects: 1900

Group type: COMPARATOR
Intervention: Control group received $0 per call
Number of subjects: 1900
Study: 30371278

Group type: EXPERIMENTAL
Intervention: Systolic BP <130 mm Hg
Number of subjects: 5380

Group type: EXPERIMENTAL
Intervention: Diastolic BP <80 mm Hg
Number of subjects: 5380

Group type: COMPARATOR
Intervention: Systolic BP 131 to 140 mm Hg (reference group)
Number of subjects: 5380

Group type: COMPARATOR
Intervention: Diastolic BP 81 to 90 mm Hg (reference group)
Number of subjects: 5380
Study: 27030562

Group type: EXPERIMENTAL
Intervention: Robotic therapy using the Multi Joint System (MJS) device for 40 min, 5 days/week for 3 weeks, in addition to standard therapeutic physical exercises, massage, laser and pulsed current therapy.
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard therapeutic physical exercises, massage, laser and pulsed current therapy (control group).
Number of subjects: 52
Study: 25996101

Group type: EXPERIMENTAL
Intervention: Concurrent neoadjuvant chemoradiotherapy (XELOX regimen)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 76
Study: 23213070

Group type: EXPERIMENTAL
Intervention: Allopurinol (100 mg or 300 mg)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 21788967

Group type: EXPERIMENTAL
Intervention: Doxazosin (4 mg) plus tolterodine SR (4 mg)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Doxazosin (4 mg) plus placebo
Number of subjects: 176
Study: 19880460

Group type: EXPERIMENTAL
Intervention: STAR*D intervention (medication switching and augmentation)
Number of subjects: 0
Study: 16391588

Group type: EXPERIMENTAL
Intervention: alpha‐tocopherol 200 mg and ascorbic acid 100 mg twice daily
Number of subjects: 174
Study: 15349657

Group type: EXPERIMENTAL
Intervention: Coptis root membrane
Number of subjects: 30

Group type: COMPARATOR
Intervention: Iodine glycerin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Single drug membrane
Number of subjects: 30

Group type: COMPARATOR
Intervention: Blank control group
Number of subjects: 30
Study: 10940443

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (responders)
Number of subjects: 0
Study: 9279492

Group type: EXPERIMENTAL
Intervention: Cocaine Stimuli Condition (0.4 mg/kg delivery of cocaine)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Neutral Stimuli Condition (placebo, 5 mg)
Number of subjects: 10
Study: 8333814

Group type: EXPERIMENTAL
Intervention: Weight loss diet
Number of subjects: 587

Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: Chlorthalidone, 25 mg/d
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: Atenolol, 50 mg/d
Number of subjects: 587
Study: 2906255

Group type: EXPERIMENTAL
Intervention: Etintidine (E) HCl in capsules, ascending doses at 72‐h intervals
Number of subjects: 12
Study: 29206721

Group type: EXPERIMENTAL
Intervention: Fostemsavir
Number of subjects: 251

Group type: COMPARATOR
Intervention: Ritonavir‐boosted atazanavir (ATV/r)
Number of subjects: 251
Study: 28790056

Group type: EXPERIMENTAL
Intervention: Alcoholic chlorhexidine (0.5% chlorhexidine in 70% ethanol)
Number of subjects: 916

Group type: COMPARATOR
Intervention: Aqueous chlorhexidine (0.5% chlorhexidine aqueous solution)
Number of subjects: 916

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 916
Study: 26286128

Group type: EXPERIMENTAL
Intervention: Managing Cancer and Living Meaningfully (CALM) intervention group (IG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual non-manualized supportive psycho-oncological intervention (SPI) control group (CG)
Number of subjects: 0
Study: 23743161

Group type: EXPERIMENTAL
Intervention: Yiqi Huaju Qingli formula treatment in combination with Western medicine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo in combination with Western medicine
Number of subjects: 60
Study: 21443586

Group type: EXPERIMENTAL
Intervention: Glucose tablets
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Jellybeans
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Orange juice
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Sugar mints (Mentos dragees®)
Number of subjects: 39
Study: 18959452

Group type: EXPERIMENTAL
Intervention: Mothers' singing (recorded singing songs of their choice for use at home, played 20 minutes per day, 3 to 5 times per week)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no singing intervention)
Number of subjects: 90
Study: 16856623

Group type: EXPERIMENTAL
Intervention: peg‐IFN‐alpha2a (180 microg/week) plus RBV (800mg/day)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: peg‐IFN‐alpha2b (1.5 microg/kg/week) plus RBV (800‐1,200mg/day)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: VOSE group
Number of subjects: 34
Study: 15676315

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 25

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 25
Study: 10935680

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 504
Study: 8708519

Group type: EXPERIMENTAL
Intervention: Isoniazid prophylaxis
Number of subjects: 46

Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 46
Study: 1855729

Group type: EXPERIMENTAL
Intervention: Heparin-surface-modified PMMA IOL
Number of subjects: 53

Group type: COMPARATOR
Intervention: Regular PMMA lenses (Control)
Number of subjects: 53
Study: 7042110

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (2.0 g i.v. on admission and 2.0 g i.v. 3 hours later)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (identical schedule as methylprednisolone)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Methylprednisolone and Placebo
Number of subjects: 40
Study: 31755803

Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Thyroxine treatment (Group A)
Number of subjects: 554

Group type: COMPARATOR
Intervention: No treatment (Group B)
Number of subjects: 554
Study: 31060544

Group type: EXPERIMENTAL
Intervention: Gastrectomy, CRS and HIPEC after 3-4 cycles of systemic chemotherapy
Number of subjects: 106

Group type: COMPARATOR
Intervention: Palliative systemic chemotherapy only
Number of subjects: 106
Study: 28643618

Group type: EXPERIMENTAL
Intervention: Heat-stabilised rice bran (30 g/d)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (no additional ingredient)
Number of subjects: 19
Study: 26056862

Group type: EXPERIMENTAL
Intervention: Oriental medicine music therapy (OMMT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 30
Study: 23361061

Group type: EXPERIMENTAL
Intervention: Massage Therapy (MT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control
Number of subjects: 21
Study: 21391002

Group type: EXPERIMENTAL
Intervention: Moving-window method for examining continuous covariates and missing IVUS values
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Last observation carried forward (LOCF) method for imputing lipid endpoints
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple imputation approach for missing covariates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Identified key contributors to missing IVUS endpoint
Number of subjects: 0
Study: 18539337

Group type: EXPERIMENTAL
Intervention: Continuation phase cognitive therapy (C‐CT) for 8 months
Number of subjects: 84

Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: C‐CT
Number of subjects: 84
Study: 17463374

Group type: EXPERIMENTAL
Intervention: Coping skills intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care group
Number of subjects: 0
Study: 15510599

Group type: EXPERIMENTAL
Intervention: UDCA (500 mg b.i.d)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 11566517

Group type: EXPERIMENTAL
Intervention: Hydroview IOL (Storz Hydroview H60M)
Number of subjects: 60

Group type: COMPARATOR
Intervention: PMMA IOL (Storz P497UV)
Number of subjects: 60
Study: 9562365

Group type: EXPERIMENTAL
Intervention: CrH2O (4 x 5 g of CrH2O and 1 g glucose/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (4 x 6 g of glucose/day)
Number of subjects: 15
Study: 7886408

Group type: EXPERIMENTAL
Intervention: Thoracoretroperitoneal approach with saphenous vein bypass grafting
Number of subjects: 16

Group type: COMPARATOR
Intervention: Transabdominal approach with Dacron prosthesis
Number of subjects: 16
Study: 3346979

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 3234

Group type: COMPARATOR
Intervention: Thiazide diuretics
Number of subjects: 3234

Group type: EXPERIMENTAL
Intervention: Metoprolol (in smokers)
Number of subjects: 3234
Study: 30893169

Group type: EXPERIMENTAL
Intervention: Prabotulinumtoxin A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Onabotulinumtoxin A
Number of subjects: 0
Study: 29110679

Group type: EXPERIMENTAL
Intervention: 0.1 mmol/kg body-weight of gadobutrol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.2 mmol/kg body-weight of gadobutrol
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.1 mmol/kg gadobutrol
Number of subjects: 60
Study: 25788173

Group type: EXPERIMENTAL
Intervention: Band and loop (B&L) space maintainers
Number of subjects: 36

Group type: COMPARATOR
Intervention: Crown and loop (C&L) space maintainers
Number of subjects: 36
Study: 23306828

Group type: EXPERIMENTAL
Intervention: Heidelberg retinal tomography (HRT) 3
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Frequency-doubling technology (FDT) perimetry
Number of subjects: 117
Study: 21500240

Group type: EXPERIMENTAL
Intervention: Regression Discontinuity Design (RDD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional Group Randomized Trial (GRT)
Number of subjects: 0
Study: 18652323

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with inductance coupling treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 60
Study: 16827023

Group type: EXPERIMENTAL
Intervention: Inlay restoration
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Onlay with only lingual cuspal coverage
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Onlay with buccal and palatal cuspal coverage
Number of subjects: 120

Group type: COMPARATOR
Intervention: Intact teeth (control group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 10-mm diameter steel ball
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 3-mm diameter steel ball
Number of subjects: 120
Study: 12837183

Group type: EXPERIMENTAL
Intervention: Gelofusion resuscitation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Plasma resuscitation
Number of subjects: 20
Study: 10751520

Group type: EXPERIMENTAL
Intervention: Hypoxia (PET,O2 55 mmHg; 7.3 kPa)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (continued euoxia; PET,O2 100 mmHg; 13.3 kPa)
Number of subjects: 6
Study: 8601116

Group type: COMPARATOR
Intervention: Active treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nomogram for calculations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Relative risk reduction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Time periods
Number of subjects: 0
Study: 1536482

Group type: EXPERIMENTAL
Intervention: Left lateral decubitus position
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Right lateral decubitus position
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 12
Study: 6233093

Group type: EXPERIMENTAL
Intervention: alpha-methyldopa
Number of subjects: 20

Group type: COMPARATOR
Intervention: propranolol
Number of subjects: 20
Study: 30879395

Group type: EXPERIMENTAL
Intervention: Motor intervention (ABC learning approach)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Motor intervention (ABC learning approach) + regular educational services
Number of subjects: 45

Group type: COMPARATOR
Intervention: Regular educational services
Number of subjects: 45
Study: 30146141

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT) with homework completion after Sessions 2 and 3
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT) with homework completion after Sessions 8 and 9
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT) in the second half of treatment
Number of subjects: 140
Study: 25057809

Group type: EXPERIMENTAL
Intervention: High-saturated fatty acid (HSFA) diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-monounsaturated fatty acid diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-fat, high-complex carbohydrate diet with n-3 polyunsaturated fatty acids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-fat, high-complex carbohydrate diet with placebo
Number of subjects: 0
Study: 22761409

Group type: EXPERIMENTAL
Intervention: Therapeutic drug monitoring (TDM) of voriconazole
Number of subjects: 110

Group type: COMPARATOR
Intervention: Non-therapeutic drug monitoring (non-TDM) of voriconazole
Number of subjects: 110
Study: 20465650

Group type: EXPERIMENTAL
Intervention: Multivitamin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vitamin C
Number of subjects: 20
Study: 18703472

Group type: EXPERIMENTAL
Intervention: Tibolone (1.25 mg once daily)
Number of subjects: 4538

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4538
Study: 15851913

Group type: EXPERIMENTAL
Intervention: HIV-infected women
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (healthy female subjects)
Number of subjects: 100
Study: 12576957

Group type: EXPERIMENTAL
Intervention: EPA+GLA
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 67
Study: 9804518

Group type: EXPERIMENTAL
Intervention: LDL apheresis
Number of subjects: 44

Group type: COMPARATOR
Intervention: PTCA
Number of subjects: 44

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 44
Study: 7879457

Group type: EXPERIMENTAL
Intervention: Trapidil
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 2234856

Group type: EXPERIMENTAL
Intervention: Heparin surface-modified (HSM) lenses
Number of subjects: 53

Group type: COMPARATOR
Intervention: Regular PMMA lenses
Number of subjects: 53
Study: 197800

Group type: EXPERIMENTAL
Intervention: Dexamethasone (single oral dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desoxycorticosterone (single oral dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACTH (two i.v. injections of 60 IU each, at a 6-hour interval)
Number of subjects: 0
Study: 30068252

Group type: EXPERIMENTAL
Intervention: Activity tracker group
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Text messaging group
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Activity tracker + text messaging group
Number of subjects: 98
Study: 30141342

Group type: EXPERIMENTAL
Intervention: Lotus valve system (Boston Scientific, MA, USA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-expanding valve
Number of subjects: 0
Study: 28923989

Group type: EXPERIMENTAL
Intervention: Simvastatin plus ezetimibe
Number of subjects: 18131
Study: 26247327

Group type: EXPERIMENTAL
Intervention: Therapist-aided exposure treatment for 3 months
Number of subjects: 70

Group type: COMPARATOR
Intervention: Waiting list control condition
Number of subjects: 70
Study: 24093349

Group type: EXPERIMENTAL
Intervention: Visual causal model (dual-mode) presentation
Number of subjects: 190

Group type: COMPARATOR
Intervention: Auditory-only presentation
Number of subjects: 190
Study: 21178600

Group type: EXPERIMENTAL
Intervention: New back school
Number of subjects: 360

Group type: COMPARATOR
Intervention: Traditional back school (usual care)
Number of subjects: 360
Study: 18316661

Group type: EXPERIMENTAL
Intervention: Intervention to reduce television viewing and computer use by 50%
Number of subjects: 70

Group type: COMPARATOR
Intervention: Monitoring control group (no reduction in television viewing or computer use)
Number of subjects: 70